Pacific Biosciences of California, Inc. (PACB)
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Pacific Biosciences of California, Inc. (PACB)
NEW YORK, NY / ACCESSWIRE / August 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pacific Biosciences of California, Inc. ("Pacific Biosciences of California, Inc.") (NASDAQ:PACB) concerning possible violations of federal securities laws. On April 16, 2024, PACB preannounced poor Q1 2024 top-line results and then announced a significant reduction in its full-year guidance for 2024 as well as a reconsideration of their long-term guidance for fiscal year 2026.
Pacific Biosciences of California (PACB) Flat As Market Sinks: What You Should Know
The latest trading day saw Pacific Biosciences of California (PACB) settling at $2.05, representing no change from its previous close.
Pacific Biosciences of California (PACB) Ascends While Market Falls: Some Facts to Note
Pacific Biosciences of California (PACB) concluded the recent trading session at $1.88, signifying a +1.62% move from its prior day's close.
PacBio's (PACB) Revio System to Boost Novogene's German Lab
PacBio (PACB) announces that Novogene is set to use PACB's Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany.
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
PacBio (PACB) and Form Bio to Boost AAV Industry Development
PacBio (PACB) and Form Bio collaborate to form an expert AAV Working Group to introduce essential tools for AAV development and research professionals.
Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors
In the most recent trading session, Pacific Biosciences of California (PACB) closed at $1.37, indicating a +0.74% shift from the previous trading day.
Reasons to Retain PacBio (PACB) Stock in Your Portfolio
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
Pacific Biosciences of California, Inc. (PACB) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Pacific Biosciences (PACB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
